Abstract
In this paper we describe the development of a novel series of non-peptide, "balanced" neuromedin-B preferring (BB1)/gastrin-releasing peptide preferring (BB2) receptor ligands as exemplified by PD 176252. PD 176252, which exhibits nanomolar affinity for both the BB1 (Ki = 0.15 nM) and BB2 (Ki = 1.0 nM) receptors, has been demonstrated to be a competitive antagonist at these bombesin receptor subtypes.
MeSH terms
-
Animals
-
Gastrin-Releasing Peptide / metabolism
-
Humans
-
Indoles / chemistry
-
Indoles / metabolism*
-
Kinetics
-
Ligands
-
Models, Chemical
-
Neurokinin B / analogs & derivatives
-
Neurokinin B / metabolism
-
Rats
-
Receptors, Bombesin / antagonists & inhibitors*
-
Species Specificity
-
Structure-Activity Relationship
Substances
-
Indoles
-
Ligands
-
PD 165929
-
Receptors, Bombesin
-
Gastrin-Releasing Peptide
-
Neurokinin B
-
neuromedin B
-
PD 176252